BioSpace News Archive

Dr. Gregory Chernoff, F.R.C.S.(C) of Chernoff Plastic Surgery www.drchernoff.com and in conjunction with the Department of Otolaryngology, Head and Neck Surgery, St. Vincent Hospital, Indianapolis, Indiana, announces his published Study: https://www.scireslit.com/Pharmaceutica/IJPAA-ID18.pdf in the International Journal of Pharmaceutica Analytica Acta.

Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today that the company has appointed Robert Jordan, Ph.D., Vice President, Research and Development. Dr. Jordan has more than 20 years of virology research and antiviral drug development experience in both academia and industry. He was most recently Director, Virology at Vir Biotechnolo

A transformative innovation Gemini™, the in silico patient, will drive better drug development, clinical trial design and generation of real-world evidence in multiple myeloma [25-June-2020] CAMBRIDGE, Mass. , June 25, 2020 /PRNewswire/ -- GNS Healthcare, an AI-driven precision medicine company, today announced the launch of Gemini TM , the in silico multiple myelom

Vertex Foundation Announces $1.5 Million Gift to Boston University’s New Center for Antiracist Research

IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“ IntelGenx ” or the “ Corporation ”) today announced that the holders (“ Debentureholders ”) of its 8.0% convertible unsecured subordinated debentures due June 30, 2020, originally issued on July 12, 2017 and August 8, 2017 (the “ Debentures ”), have approved the proposed amendments to the Debentures at the convened meeting of debentureholders held today. As a result, the maturity d

HITRUST CSF Certification validates Enclara Pharmacia is committed to meeting key regulations and protecting sensitive information

Minnesota medical device startup Cryosa completed its Series A-2 funding, raising $8.25 million to further develop its breakthrough therapies for obstructive sleep apnea (OSA). The round was led by life sciences firm, Santé Ventures, and HOYA Corporation (“HOYA”), with additional institutional and individual investors. This latest funding round will be used to engage in first-in-human clinical trials. The compa

Olympus®, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced that it is hosting a live panel discussion about the practice of flexible endoscopy during the COVID-19 pandemic with three leading Otolaryngologists

The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for a rapid COVID-19 antibody test distributed by Virality Diagnostics LLC, manufactured by Biohit (Hefei).

If scientists understood how Alzheimer’s disease starts, they might have a better handle on how to stop it. That’s the premise behind a new $40.5 million collaborative research center in Seattle to build high-resolution maps of Alzheimer’s patients’ brains and identify how their neurons and other brain cells differ from those of healthy people.